3 . 2014

Ulipristal acetate in leiomyomas treatment

Tigieva A.V.

Abstract

Leiomyoma is one of the most common gynecological diseases. The main treatment for uterine fibroids is surgery. An effective drug for the treatment of this pathology is not still developed.

Studies have shown the effectiveness of the progesterone receptor modulator ulipristal acetate in the preoperative treatment of leiomyomas and the control of concomitant menorrhagia.

Keywords:leiomyoma, ulipristal acetate, selective progesterone receptor modulators

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITORS

Sukhikh Gennadii Tikhonovich

Academician of the Russian Academy of Medical Sciences, V.I. Kulakov Obstetrics, Gynecology and Perinatology National Medical Research Center of Ministry of Healthсаre of the Russian Federation, Moscow

Kurtser Mark Arkadievich

Academician of the Russian Academy of Sciences, MD, Professor, Head of the Obstetrics and Gynecology Subdepartment of the Pediatric Department, N.I. Pirogov Russian National Scientific Research Medical University, Ministry of Health of the Russian Federation

Radzinsky Viktor Evseevich

Corresponding Member of the Russian Academy of Sciences, MD, Professor, Head of the Subdepartment of Obstetrics and Gynecology with a Course of Perinatology of the Medical Department in the Russian People?s Friendship University

Buy a number Subscribe